IQI
PFE icon

Integrated Quantitative Investments’s Pfizer PFE Stock Holding History

Integrated Quantitative Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,179
Closed -$310K – 481
2025
Q3 		$310K Buy
+12,179
New +$301K 0.09% 263
2025
Q2 		– Sell
-19,300
Closed -$489K – 425
2025
Q1 		$489K Buy
+19,300
New +$505K 0.24% 136

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Integrated Quantitative Investments's PFE Position: Q4 2025 in Review

Integrated Quantitative Investments sold out of Pfizer (PFE) in Q4 2025, closing a stake of 12,179 shares — an estimated $310K sold.

Integrated Quantitative Investments first reported a position in PFE in Q1 2025 and held it in 2 quarters. The position peaked at $489K in Q1 2025. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Integrated Quantitative Investments reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Integrated Quantitative Investments sold 12,179 Pfizer shares in Q4 2025, an estimated $310K.
  • Integrated Quantitative Investments first reported a position in Pfizer in Q1 2025 and held it in 2 quarters.
  • Integrated Quantitative Investments's Pfizer position peaked at $489K in Q1 2025.
  • 2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Integrated Quantitative Investments's 13F filing for Q4 2025, filed 12 Feb 2026.